Thalassemia continues to be a significant health challenge in India, but with advancements in healthcare, early diagnosis, ...

After a long struggle, and with the help of Frank Vella, a biochemist from Singapore University, we found that this child had thalassemia, an inherited blood disease that was thought at the time ...

It’s been almost a year since the Food and Drug Administration approved the first genetic treatments for sickle cell disease.

Mitapivat shows promise in treating SCD and thalassemia, with ongoing Phase 3 trials showing positive results for hemoglobin improvement. Expanding Pyrukynd’s label to include pediatric and ...

The severity of these rarer types of sickle cell disease varies. — Hemoglobin S–beta-thalassemia: When individuals are diagnosed with this form of sickle cell disease, they inherit one sickle cell ...

Children ages 12 and older with sickle cell are now eligible for a newly FDA-approved treatment through the MACC Fund Center ...

HYDERABAD: The Pakistan Study Centre (PSC) at the University of Sindh in collaboration with ESSA Lab and the Rotary Club of ...

Patients in Indore are now receiving advanced medical facilities, with the state's first government Super Speciality Hospital introducing haploidentical stem cell transplant (commonly known as haplo ...

Considering taking supplements to treat beta thalassemia? Below is a list of common natural remedies used to treat or reduce the symptoms of beta thalassemia. Follow the links to read common uses ...

Are you searching for medications to treat 'Thalassemia'? Welcome to this page which serves as an archive for medications that are relevant to the treatment of Thalassemia. The page includes both ...

The MACC Fund Center for Cancer and Blood Disorders at Children’s Wisconsin is now offering a new gene therapy to children ...

The biotech stock's price-to-earnings-to-growth (PEG) ratio is a super-low 0.58, according to the London Stock Exchange Group (LSEG). Any PEG ratio below 1.0 is viewed as an attractive valuation.